Theravance Biopharma, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Theravance Biopharma, Inc. (TBPH) is 13.14

According to Theravance Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.14. This represents a change of 30.60% compared to the average of 10.06 of the last 4 quarters.

Theravance Biopharma, Inc. (TBPH) Historical Current Ratio (quarterly & annually)

How has TBPH Current Ratio performed in the past?

The mean historical Current Ratio of Theravance Biopharma, Inc. over the last ten years is 6.63. The current 13.14 Current Ratio has changed 19.72% with respect to the historical average. Over the past ten years (40 quarters), TBPH's Current Ratio was at its highest in in the March 2026 quarter at 13.14. The Current Ratio was at its lowest in in the December 2019 quarter at 3.03.

Theravance Biopharma, Inc. (TBPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Theravance Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theravance Biopharma, Inc. (TBPH) Average Current Ratio

How has TBPH Current Ratio performed in the past?

The current Current Ratio of Theravance Biopharma, Inc. (TBPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Theravance Biopharma, Inc. (TBPH) Current Ratio vs. Peers

How is TBPH’s Current Ratio compared to its peers?

Theravance Biopharma, Inc.’s Current Ratio is greater than BlackRock Technology and Private Equity Term Trust (0.13), greater than Monte Rosa Therapeutics, Inc. (9.54), greater than Day One Biopharmaceuticals, Inc. (8.02), greater than Geron Corporation (6.78), greater than Replimune Group, Inc. (5.60), greater than Vir Biotechnology, Inc. (7.11), greater than LENZ Therapeutics, Inc. (10.40), less than ArriVent BioPharma, Inc. Common Stock (13.95), greater than Valneva SE (2.14), less than Tyra Biosciences, Inc. (20.49),

Build a custom stock screener for Theravance Biopharma, Inc. (TBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theravance Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theravance Biopharma, Inc. (TBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theravance Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.